$OPNT News Article - Opiant Pharmaceuticals Announces

New Post Public Reply Private Reply Replies (0) Message Board Keep
whytestocks
175
$OPNT News Article - Opiant Pharmaceuticals Announces Positive Pharmacokinetic, Safety, and Tolerability Results From a Multi-Dose Study for OPNT003, Nasal Nalmefene https://marketwirenews.com/news-releases/opia...40178.html

Opnet Technologies Inc. (OPNT) Stock Research Links

OPNT Board Company Profile Buy Rating Time & Sales News Filings Financials
My Twitter: WhyteStocks